BEST of the BROKERS

CINEWORLD
Numis rates the cinema group as “add” with a target price of 240p and expects a 10 per cent rise in pre-tax profit to £13.6m when it posts half-year results on Thursday, based on a 4.1 per cent boost to box office revenue.

HIKMA PHARMACEUTICALS
Shore Capital rates the pharma group as a “buy” with a target price of 704p, expecting a strong rebound in its first-half results due this Thursday, after last year was negatively hit by the Arab Spring.

OCADO
Panmure Gordon rates the groceries delivery service at “sell” with a target price of 50p. The broker says the firm is “standing alone against the largest retailers in the country with a pile of debt, and falling market share isn’t sustainable.”